Alico Inc
NASDAQ:ALCO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
24.39
30.56
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Alico Inc
Earnings Call Analysis
Summary
Q1-2024
Alico achieved a remarkable turnaround with a net income of $42.9 million for Q1 2024 compared to a net loss of $3.2 million in the previous year, largely due to selling 17,229 acres of Alico Ranch. They offloaded $44 million in total debt, bettering their balance sheet strength. Although early harvests were underwhelming, causing a $10.8 million inventory write-down, they are hopeful for the Valencia crop. Harvest challenges persist from Hurricane Ian, but a 30.1% increase in process box production lifted revenues by $3.3 million. With $95 million in undrawn credit and aggressive debt repayment from ranch sale proceeds, Alico fortifies its position for a brighter future bolstered by vast Florida agriculture experience and intentions to apply OTC therapy to all citrus trees, expecting significant fruit yield improvements.
You don't have any saved screeners yet
Welcome to Alico's First Quarter 2024 Earnings Conference Call. [Operator Instructions] And as a reminder, today's conference is being recorded.
Last night, the company issued a press release announcing its results for the first quarter ended December 31, 2023. If you have not had the chance to view the release, it is available on the Investor Relations portion of the company's website at alicoinc.com. This call is being webcast, and a replay will be available on Alico's website as well.
Before we begin, we would like to remind everyone that the prepared remarks today contain forward-looking statements. Such statements are subject to risks, uncertainties and other factors may cause actual results to differ materially from those expressed or implied in these statements. Important factors that could cause or contribute to such differences include risk details in the company's quarterly reports on Form 10-Q and annual reports on Form 10-K, current reports Form 8-K and any thereto filed with the SEC and those mentioned in the earnings release.
The company undertakes no obligation to subsequently update or revise the forward-looking statements made on today's call except as required by the law.
During this call, the company will also discuss non-GAAP financial measures including EBITDA, adjusted EBITDA and net debt. For more details on these measures, please refer to the company's press release issued earlier today.
With that, I would like to turn the conference call over to the company's President and CEO, Mr. John Kiernan. Please go ahead.
Thank you, [ Kelsey ], and thank you, everyone, for joining us for Alico's First Quarter 2024 Earnings Call this morning. As previously announced, on September 18, 2023, Alico signed a contract with the State of Florida to sell the remaining 17,229 acres of the Alico Ranch and on December 21, 2023, we closed on the sale for $77.6 million in gross proceeds. A portion of the proceeds from this sale were used to repay the outstanding balance on our working capital line of credit and $19.1 million of Metlife variable rate term loans plus accrued interest. The remainder, we retained in cash.
Results from our early and mid-season harvest this season were disappointing resulting in an inventory write-down of approximately $10.8 million in the first quarter of fiscal year 2024. We believe that the early and mid-season box production was affected by the continued impact of Hurricane Ian. We are cautiously optimistic that our Valencia crop, which we'll begin harvesting soon will show a stronger rate of recovery. That harvest is expected to begin in another week or so.
In January 2024, the company received funding from the Citrus Research and Field Trial Foundation to support our use of oxytetracycline to combat the effect of greening in the citrus trees. Last year, beginning in January 2023, over 35% of our producing trees were treated with an OTC trunk injection with the expectation that would improve fruit quality and decrease the rate of fruit drop. We expect that the full extent of the benefits of these prior year OTC treatments will not be measurable until the full 2023-'24 harvest is completed. Also last month, we published our 2023 Annual Sustainability Report highlighting our approach to sustainability and progress with our environmental, social and government -- governance priorities.
We believe that our balance sheet remains one of our greatest strengths as we continue to operate in a challenging citrus industry. Because of the sale of the remaining acreage of Alico Ranch, we have been able to reduce our total debt by $44 million and our net debt by almost $62 million, representing a decrease of 34% in our total debt and a decrease of 48% in our net debt in each case from September 30, 2023 to December 31, 2023.
Even more importantly, we have the full $95 million available of undrawn credit, which is comprised of approximately $70 million on our working capital line, which matures in November 2025 as well as $25 million of undrawn credit on the revolving line of credit, which matures in November of 2029. We believe that these credit facilities provide Alico with ample liquidity, while the company continues to recover from the impact of recent weather events.
With that, I will turn the call over to Brad to discuss our more detailed financial results.
Thank you, John. Good morning, everyone. I'd like to remind everyone that our business is seasonal, and the majority of our citrus crop is harvested in the second and third quarters of the fiscal year, with the majority of our profit and cash flow is also recognized in the second and third quarters. Quarterly results for the first quarter are not indicative of our full year results.
The $3.3 million increase in revenue for the 3 months ended December 31, 2023, as compared to the 3 months ended December 31, 2022, was primarily due to a 24.9% increase in pound solids, driven by a 30.1% increase in process box production, as we began to recover from the effects of Hurricane Ian.
Our food production for the 3 months ended December 31, 2022, was adversely impacted by the fruit drop caused as a result of the impact of Hurricane Ian in September '22. And although hurricane initially impacted the fiscal year 2023 harvest, we expected to take another season or more for the growth to recover the pre hurricane production levels. In addition, there was an increase in the price per pound sold of 3.4% for the 3 months ended December 31, 2023, compared to the same period in the prior year as a result of more favorable pricing in one of our contracts with Tropicana.
Total operating expenses were $28.2 million and $14.4 million for the fiscal first quarters ended December 31, 2023, and 2022, respectively. The increase in operating expenses primarily relates to the $10.8 million adjustment to reduce our inventory to its net realizable value as a result of significantly lower-than-anticipated box production from our early and mid-season crop due to the ongoing effects of Hurricane Ian as well as an increase in harvest and all costs driven by our increased box production and approximately $1.3 billion we received in the quarter ended December 31, 2022, which was the last installment of the Florida citrus block grant program for the 2017 storm, Hurricane Irma.
General and administrative expenses for the 3 months ended December 31, 2023, and 2022 were $3.3 million and $2.5 million, respectively. The increase was primarily due to an increase in salary and wages of $0.6 million and consulting fees principally related to real estate entitlement activities of $0.3 million. Other income expense, net, for the 3 months ended December 31, 2023, and 2022, was $75.5 million and $2 million, respectively. The increase is primarily due to the sale of 17,229 acres of the Alico Ranch to the State of Florida.
For the first fiscal quarter ended December 31, 2023, the company reported net income attributable to common -- attributable to Alico common stockholders of $42.9 million, compared to a net loss of $3.2 million for the first fiscal quarter ended December 31, 2022, driven by the aforementioned sale of the Alico Ranch.
I'll now pass the call back to John.
Thanks, Brad. Although the first part of our harvest season was off to a slow start, which we believe was because of Hurricane Ian, we remain cautiously optimistic that our upcoming Valencia harvest will show stronger improvement from the effects of Hurricane Ian.
Alico has over 125 years of experience as a leader in Florida agriculture and land management. Since 2017, we planted over 2.2 million new trees, and we remain committed to the Florida citrus industry for the long term. We plan to apply the OTC therapy to substantially all of our producing trees in fiscal year 2024 and believe that this treatment, combined with the recent tree plantings that are maturing in consistent caretaking practices, should support a significant increase in fruit harvest in next season.
In addition, Alico is continuing to evaluate all of our properties to determine the highest and best use to create long-term value for our shareholders. We strive to provide our investors with the benefits and stability of conventional agricultural investment with the enhanced optionality that comes through active land management.
And with that, we'll now open the line up to questions from industry analysts. [ Kelsey ]?
[Operator Instructions] And your first question comes from Gerry Sweeney from ROTH Capital.
Wanted to talk about the harvest. Obviously, you've said in the past, it could take up to 2 years for the harvest to rebound. So -- but maybe a little bit below my expectations, which totally understandable with this ag. But curious, is this just -- wanted to talk about maybe the actual trees and orchards. We've talked in the past that there was no structural damage to trees. Is this just a longer rebound that's going to take 2 years? Or is there any concern that there may have been some structural damage to the trees from the hurricane that would reduce output?
Thanks, Gerry. That's a great question. As we reported back in 2022, we lost relatively few trees compared to our entire portfolio. It's clear that 150-mile an hour winds for the sustained amount of hours that affected a majority of our growth definitely stressed the trees out. And we think that is directly attributable to why they have not rebounded from the effects of that storm as quickly as they did in the previous storm back in 2017 when Hurricane Irma hit.
We don't think that this permanent damage to the trees. We just think that trees are taking a little bit longer to come back. We did flag that it could take up to 2 years back in 2022. We think our peers are suffering as well that they're not seeing a robust rebound as quickly as we did previously. But we do not think that there is permanent structural damage to the trees themselves.
Got it. And then you talked about OTC and I think, [ administrating ] it to the rest of your orchards, I believe, about 35% of your crop has been treated with it. Now given the -- your results on the early mids, can you see a difference between -- and I know the harvest is down for sure obviously. But I was just curious if you're seeing a difference in the production where OTC was administered to the early mids as opposed to trees that were -- have not been treated yet?
Another great question, obviously. Last year was the first year we kind of piloted the treatment once it was approved by the FDA last January. We definitely saw a noticeable improvement from our control groups for the early mids. In this past harvest season, we're just having a little trouble quantifying it. But we applied about 3x as many applications to our Valencia trees last season as we did to the early mids, so we have a much larger sample size comparable to the control group. So we'd like to reserve until the end of this harvest season a full evaluation to quantify kind of what the improvement was, but it is visible and noticeable.
Cautiously optimistic. So -- got it. Got it. That's fair. And then final question. Obviously, contracts, I think some of the -- at least larger percentage of some of your fruit is coming up with contract renewal this year. Just any comments on that front or -- and around what you're looking at or timing or when we should hear when that would be completed.
So it is early days. We are basically putting out to bid the replacement for the current contract that expires at the end of the season for I think it's 3/4 of our acres. So it is material, but we anticipate that no later than when we release the third quarter queue in August, but I'll keep my fingers crossed, we may have some better news to report that maybe we get it done by May. But right now, we really have no details that we can share other than we're actively in the bid process.
Got it. And that contract would be for next year not this year.
Correct. That would start in November, December.
And there are no further questions at this time. Mr. Kiernan, you can proceed.
I just want to thank everyone for joining our call today and for your continued support of Alico. We look forward to speaking with you all about our second quarter results in May. Have a good day.
Ladies and gentlemen, this concludes your conference call for today. We thank you very much for participating and ask that you please disconnect your lines. Have a great day.